This clinical trial examines the effectiveness in acute low back pain (LBP) of three medications: Ketorolac, Ibuprofen, Diclofenac.
This is an interventional study with an estimated 198 participants. It is randomized and double blind for the primary purpose of treating low back pain. The estimated start date of the study is in June 2019 and its estimated completion is in December 2019.
- All genders, ages 18-64 years old
- Present to ED primary for management of Low Back Pain (LBP)
- Functionally impairing back pain: A baseline score greater than 5 on the Roland-Morris Disability Questionnaire
- Musculoskeletal etiology of low back
- Non-radicular pain.
- Pain duration less than 2 weeks (336 hours)
- Non-traumatic LBP
- Participant is to be discharged home
- Flank pain: pain originating from tissues lateral to the paraspinal muscles.
- Not available for follow-up
- Chronic pain syndrome
- Allergic to or intolerant of investigational medications
- Contraindications to investigational medications
You may participate in this study at Montefiore Medical Center in Bronx, New York, United States, 10467. If you have any questions or concerns please contact Eddie Irizarry, MD.
This study is sponsored by Montefiore Medical Center with Eddie Irizarry, MD as the Principal Investigator.
Clinical TrialsView All Clinical Trials
Selecting Effective Combinations of Treatment for Low Back Pain
The #1 contributor to to United States disability claims is chronic back pain – specifically lower back pain…
Meditation and Exercise to Treat Chronic Back Pain
This clinical trial examines the effectiveness of meditation and exercise on individuals with chronic back pain.…
Examining Racial and SocioEconomic Disparities in Chronic Low Back Pain Study
There is little supporting evidence on whether disadvantaged groups of society may have a higher risk for chronic…